CVS Health Appoints David Joyner President and Chief Executive Officer
October 19, 2024
October 19, 2024
WOONSOCKET, Rhode Island, Oct. 19 -- CVS Health issued the following news release on Oct. 18, 2024:
* * *
Roger Farah Named Executive Chairman of the Board
Company provides preliminary guidance for third quarter 2024 GAAP diluted Earnings per Share (EPS) of $0.03 to $0.08 and Adjusted EPS of $1.05 to $1.10
* * *
CVS Health (NYSE: CVS) today announced that David Joyner was appointed President and Chief Executive Officer, effective O . . .
* * *
Roger Farah Named Executive Chairman of the Board
Company provides preliminary guidance for third quarter 2024 GAAP diluted Earnings per Share (EPS) of $0.03 to $0.08 and Adjusted EPS of $1.05 to $1.10
* * *
CVS Health (NYSE: CVS) today announced that David Joyner was appointed President and Chief Executive Officer, effective O . . .